Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Brief Commentary
Cardio Oncology with ACOS
Case Report
Case Series
Conference Review
Consensus Statement
Current Issue
Editorial
Erratum
From the Editor’s Desk
Letter to Editor
Media and News
Molecular Insight Story
New Drug Update
News
Original Article
Position Paper
Response to the letter
Review Article
Short Communication
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Brief Commentary
Cardio Oncology with ACOS
Case Report
Case Series
Conference Review
Consensus Statement
Current Issue
Editorial
Erratum
From the Editor’s Desk
Letter to Editor
Media and News
Molecular Insight Story
New Drug Update
News
Original Article
Position Paper
Response to the letter
Review Article
Short Communication

Most Viewed Articles


Articles Fulltext downloads PDF downloads Total downloads
Short Communication
Driver mutations in oncogenesis
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May-August
DOI: 10.25259/IJMIO_26_2020
35,385 3,994 39,379
Short Communication
Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in Bangladesh
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 1, January-April
DOI: 10.25259/IJMIO_30_2020
30,146 3,080 33,226
Review Article
Mini review: Molecular pathology of personalized medicine in cancer susceptibility syndromes
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 3, September-December
DOI: 10.25259/IJMIO_12_2023
28,364 2,588 30,952
Editorial
Challenging conventional wisdom in molecular oncology: New perspectives
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 3, September-December
DOI: 10.25259/IJMIO_20_2023
26,857 2,445 29,302
Original Article
Outcomes with atezolizumab and bevacizumab in hepatocellular carcinoma – Real-world data from India
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 3, September-December
DOI: 10.25259/IJMIO_15_2023
26,670 2,461 29,131
Case Report
Long-term efficacy of osimertinib in de novo exon 19 deletion with T790M in an epidermal growth factor receptor mutated lung cancer patient in India
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2024, Volume: 9, Issue: 1, January-April
DOI: 10.25259/IJMIO_16_2023
24,175 2,531 26,706
Review Article
Molecular oncology and the role of artificial intelligence in advancing cancer treatment
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 3, September-December
DOI: 10.25259/IJMIO_17_2023
22,784 1,837 24,621
Editorial
Crucial crossroads: Making the right choice for first-line therapy in advanced urothelial cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2024, Volume: 9, Issue: 1, January-April
DOI: 10.25259/IJMIO_2_2024
17,904 2,947 20,851
Review Article
Use of five-day chronomodulated prescription of palbociclib as myelopreservation drug along with Topotecan in recurrent extensive stage small cell lung carcinoma – A perspective article
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2024, Volume: 9, Issue: 1, January-April
DOI: 10.25259/IJMIO_3_2024
18,023 2,687 20,710
Original Article
Spectrum of lymphomas in India
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2024, Volume: 9, Issue: 1, January-April
DOI: 10.25259/IJMIO_18_2023
17,902 2,021 19,923
Review Article
High-dose nicotinamide, a histone deacetylase inhibitor (Sirtuin-1), can prevent emergence of treatment resistance in chronic myeloid leukemia – A perspective
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2024, Volume: 9, Issue: 1, January-April
DOI: 10.25259/IJMIO_1_2024
16,661 2,420 19,081
News
Editorial board tribute to Dr. Amit Verma
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
16,072 2,991 19,063
Review Article
Understanding immunotherapy and CAR-T-cells: A narrative review
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2024, Volume: 9, Issue: 1, January-April
DOI: 10.25259/IJMIO_22_2023
16,695 2,199 18,894
Review Article
Can CDK 4/6 inhibitors be used in patients with visceral crises? Deviating from conventional teaching
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI: 10.25259/IJMIO_8_2022
13,677 5,076 18,753
Case Report
Clinical experience of total body irradiation performed on Halcyon™ for a patient diagnosed with acute myeloid leukemia
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI: 10.25259/IJMIO_5_2022
12,781 5,801 18,582
Case Report
Squamous cell carcinoma of lung presenting as “Sunray sign” in chest radiograph
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 3, September-December
DOI: 10.25259/IJMIO_6_2023
15,086 2,426 17,512
Cardio Oncology with ACOS
Ibrutinib and atrial fibrillation as cardiotoxicity – A new safety warning that impacts overall survival
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI: 10.25259/IJMIO_1_2022
12,404 4,473 16,877
Case Report
Hyperthermic intraperitoneal chemotherapy in primary peritoneal cancer: Our experience in a young male
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI: 10.25259/IJMIO_16_2021
14,411 2,420 16,831
Review Article
Signaling pathways in pancreatic ductile adenocarcinoma and potential therapeutic targets
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 3, September-December
DOI: 10.25259/IJMIO_29_2022
14,402 2,330 16,732
New Drug Update
Amlodipine-induced inhibition of NFAT-2 nuclear translocation and its utility as an additive to immune checkpoint inhibitor
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI: 10.25259/IJMIO_13_2021
14,213 2,304 16,517
Review Article
Is continuous infusion of high-dose ifosfamide, a safe option? Drug review
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 2, May-August
DOI: 10.25259/IJMIO_21_2019
12,676 3,699 16,375
Review Article
Combination of PARPi and anti-PD-L1 therapies in ovarian cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 2, May-August
DOI: 10.25259/IJMIO_28_2022
14,828 1,535 16,363
Review Article
Potential therapeutic molecular targets for better outcomes for patients with lung cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 2, May-August
DOI: 10.25259/IJMIO_27_2022
15,078 1,176 16,254
Original Article
Incorporation of immunohistochemistry in the assessment of survival and prognosis of endometrial cancers: Are we ready for the change?
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI: 10.25259/IJMIO_2_2022
11,471 4,388 15,859
Review Article
Immune dynamics of SARS-CoV-2 virus evolution
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 1, January-April
DOI: 10.25259/IJMIO_26_2021
11,004 4,732 15,736
Review Article
Advances in immunotherapy for metastatic esophageal cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 3, September-December
DOI: 10.25259/IJMIO_14_2022
10,858 4,537 15,395
Case Series
Dual driver in non-small cell lung carcinoma – therapeutic dilemma
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 1, January-April
DOI: 10.25259/IJMIO_22_2021
12,453 2,529 14,982
Review Article
Immuno-oncological era of breast cancer: A progressive path to better treatment
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI: 10.25259/IJMIO_3_2022
9,434 5,414 14,848
Case Report
L1CAM expressing, ZFTA:: NCOA1 fusion-positive supratentorial ependymoma: A case report
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 3, September-December
DOI: 10.25259/IJMIO_11_2023
12,920 1,727 14,647
Review Article
The evolving role of precision medicine in the management of advanced sarcomas – A mini review
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI: 10.25259/IJMIO_6_2021
11,859 2,661 14,520
Review Article
Immuno-oncology of differentiated thyroid cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May-August
DOI: 10.25259/IJMIO_36_2020
10,966 3,547 14,513
Brief Commentary
Breast cancer prognostic tools: A promising Indian option
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 2, May-August
DOI: 10.25259/IJMIO_15_2020
9,812 4,600 14,412
Review Article
Post-chemotherapy maintenance treatment by nicotinamide riboside, a poly ADP ribose polymerase 1 inhibitor, in BRCA mutated advanced ovarian cancer – A perspective
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI: 10.25259/IJMIO_12_2021
11,274 2,858 14,132
Review Article
A compendium of population wide DNA methylation profile for oral cancer in India
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May-August
DOI: 10.25259/IJMIO_2_2021
10,280 3,785 14,065
Case Report
Complete metabolic response with letrozole and palbociclib in advanced breast cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 3, September-December
DOI: 10.25259/IJMIO_2_2019
8,782 5,155 13,937
Case Report
Redefining the treatment of metastatic uveal melanoma with immunotherapy – A case report
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI: 10.25259/IJMIO_11_2022
11,097 2,836 13,933
Editorial
Nanobytes
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 3, September-December
DOI: 10.25259/IJMIO_7_2019
6,653 7,168 13,821
Review Article
The Cancer Genomic Atlas – “TO CONQUER CANCER”
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May-August
DOI: 10.25259/IJMIO_28_2020
10,209 3,485 13,694
Case Report
Unusual presentation of an Epstein barr virus-negative extranodal natural killer/T cell lymphoma: A diagnostic dilemma
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 1, January-April
DOI: 10.25259/IJMIO_18_2021
11,292 2,365 13,657
Brief Commentary
ERBB and FGFR2 pathway inhibition in biliary tract cancers – Dawn of a new beginning
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI: 10.25259/IJMIO_10_2021
10,747 2,758 13,505
Conference Review
6th Molecular Oncology Society Conference: Improving patient survival by molecularly targeted therapies
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI: 10.25259/IJMIO_20_2021
11,357 2,123 13,480
Erratum
Erratum for manuscript “Muir Torre Syndrome – An Indian Case report” (IJMIO_5_2020)
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, October
DOI: 10.25259/IJMIO_05_2020_ER
11,614 1,646 13,260
Review Article
Molecular genetics changes in gallbladder carcinoma
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 2, May-August
DOI: 10.25259/IJMIO_19_2019
8,979 4,229 13,208
Brief Commentary
Bioactive lipid: A novel diagnostic approach for retinoblastoma in clinical management
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI: 10.25259/IJMIO_7_2021
10,307 2,776 13,083
Review Article
Resistance to poly ADP-ribose polymerase inhibitors and its clinical implications
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI: 10.25259/IJMIO_12_2022
8,096 4,821 12,917
Review Article
Cell biological basis of tumor relapse and recurrence – A help from yeast quiescent biology and neuronal quiescent cell biology
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 1, January-April
DOI: 10.25259/IJMIO_18_2019
7,197 5,651 12,848
Letter to editor
Letter to editor
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI: 10.25259/IJMIO_10_2022
8,341 4,465 12,806
Review Article
Impact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent in-situ hybridization and Immunohistochemistry: A meta-analysis with systematic review
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 1, January-April
DOI: 10.25259/IJMIO_17_2019
6,585 6,129 12,714
Case Report
Metastatic endometrial carcinoma responsive to pembrolizumab
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 1, January-April
DOI: 10.25259/IJMIO_18_2020
7,276 5,407 12,683
Review Article
Antibody-drug conjugate review in breast cancer: A targeted approach
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2024, Volume: 9, Issue: 3, September-December
DOI: 10.25259/IJMIO_30_2024
5,354 7,204 12,558